Phase II trial of dendritic cell vaccine-Immunicum (INTUVAX)
Latest Information Update: 26 Sep 2022
At a glance
- Drugs Ilixadencel (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Sponsors Mendus
- 19 Feb 2014 New trial record
- 05 Dec 2013 Immunicum is expecting to initiate this trial in 2014, according to a media release.